Investments & Funding

The offering comprised 75 million ordinary shares, with 80% allocated to institutional investors and the remaining 20% reserved for individual investors.

This collaboration aims to support patients suffering from RAS-addicted cancers, a group of cancers driven by mutations in the RAS gene.

By acquiring the building outright, Burjeel Holdings has eliminated this substantial lease liability, replacing it with full ownership of a high-performing healthcare facility situated near BurJuman in Bur Dubai.

The factory will produce approximately 2,500 ultrasound devices and 40 to 50 MRI machines annually.

Under the terms of the agreement, Otsuka will obtain exclusive global rights to develop, manufacture, and commercialize HBM7020 outside of Greater China.

The initiative aims to improve public health across the Kingdom of Bahrain through a comprehensive approach that combines education, research, and community outreach.

The capital raised will primarily support the development of Actio’s two lead oral drug candidates: ABS-1230 and ABS-0871.

Konecta is recognized globally for its leadership in customer experience and digital services, combining human-centered solutions with advanced AI technologies.

The funding round was led by Access Biotechnology and attracted contributions from several prominent investors, including Canaan Partners, SR One, Schroders Capital, and Sanofi Ventures.